Hyperkalemic periodic paralysis (hyperPP) is a disorder that causes occasional episodes of muscle weakness and sometimes a higher than normal level of potassium in the blood. The medical name for high potassium level is hyperkalemia.

HyperPP is one of a group of genetic disorders that includes hypokalemic periodic paralysis and thyrotoxic periodic paralysis.

Periodic paralysis - hyperkalemic; Familial hyperkalemic periodic paralysis; HyperKPP; HyperPP; Gamstorp disease; Potassium-sensitive periodic paralysis

HyperPP is congenital. This means it is present at birth. In most cases, it is passed down through families (inherited) as an autosomal dominant disorder. In other words, only one parent needs to pass the gene related to this condition on to their child in order for the child to be affected.

Occasionally, the condition may be the result of a genetic problem that is not inherited.

It is believed that the disorder is related to problems with the way the body controls sodium and potassium levels in cells.

Risk factors include having other family members with periodic paralysis. It affects men and women equally.

Symptoms include attacks of muscle weakness or loss of muscle movement (paralysis) that come and go. There is normal muscle strength between attacks.

Attacks usually begin in childhood. How often the attacks occur varies. Some people have several attacks a day. They are usually not severe enough to need therapy. Some people have associated myotonia, in which they cannot immediately relax their muscles after use.

The weakness or paralysis:

• Most commonly occurs at the shoulders, back, and hips
• May also involve the arms and legs, but does not affect muscles of the eyes and muscles that help with breathing and swallowing
• Most commonly occurs while resting after activity or exercise
• May occur on awakening
• Occurs on and off
• Usually lasts 15 minutes to 1 hour, but may last up to an entire day

Triggers may include:

• Eating a high carbohydrate meal
• Rest after exercise
• Exposure to cold
• Skipping meals
• Eating potassium-rich foods or taking medicines that contain potassium
• Stress

The goal of treatment is to relieve symptoms and prevent further attacks.

Attacks are seldom severe enough to require emergency treatment. But irregular heartbeats (heart arrhythmias) may also occur during attacks, for which emergency treatment is needed. Muscle weakness can become worse with repeated attacks, so treatment to prevent the attacks should occur as soon as possible.

Glucose or other carbohydrates (sugars) given during an attack may reduce the severity of the symptoms. Calcium or diuretics may need to be given through a vein to stop sudden attacks.

Sometimes, attacks disappear later in life on their own. But repeated attacks may lead to permanent muscle weakness.

HyperPP responds well to treatment. Treatment may prevent, and may even reverse, progressive muscle weakness.

Health problems that may be due to hyperPP include:

• Kidney stones (a side effect of medicine used to treat the condition)
• Irregular heart beat
• Muscle weakness that slowly continues to get worse

Contact your provider if you or your child has muscle weakness that comes and goes, especially if you have family members who have periodic paralysis.

Go to the emergency room or call the local emergency number (such as 911) if you faint or have difficulty breathing, speaking, or swallowing.

The medicines acetazolamide and thiazides prevent attacks in many cases. A low potassium, high carbohydrate diet, and light exercise may help prevent attacks. Avoiding fasting, strenuous activity, or cold temperatures also may help.

Published Date: December 31, 2023
Published By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Boegle AK, Narayanaswami P. Treatment and management of disorders of neuromuscular hyperexcitability and periodic paralysis. In: Bertorini TE, ed. Neuromuscular Disorders: Treatment and Management. 2nd ed. St Louis, MO: Elsevier; 2022:chap 18.

Doughty CT, Amato AA. Disorders of skeletal muscle. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 109.

Kang MK, Kerchner GA, Ptacek LJ. Channelopathies: episodic and electrical disorders of the nervous system. In: Jankovic J, Mazziotta JC, Pomeroy SK, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 98.

Weimer M, Reese JJ, Tilton AH. Acute neuromuscular diseases and disorders. In: Zimmerman JJ, Clark RSB, Fuhrman BP, et al. Fuhrman and Zimmerman's Pediatric Critical Care. 6th ed. Philadelphia, PA: Elsevier; 2022:chap 68.